testosterone (AndroFeme®)

 

Status: Excluded due to NICE appraisal

Product meets AWMSG exclusion criteria due to NICE appraisal ID12063: Testosterone cream for treating hypoactive sexual desire dysfunction after menopause

Medicine details

Medicine name testosterone (AndroFeme®)
Formulation 10 mg/ml cream
Reference number 921
Indication

Treatment of hypoactive sexual desire dysfunction (HSDD) in postmenopausal women on optimised hormone replacement therapy (HRT)

Company Andro Pharmaceuticals Ltd
BNF chapter Endocrine system
Assessment type N/A
Status Excluded due to NICE appraisal
Scrutiny Panel meeting date 18/12/2025
Further information

This medicine was considered by the AWMSG Scrutiny Panel in December 2025 as suitable for full assessment. However, this medicine has subsequently been selected for assessment by NICE. Therefore, AWMSG will not be progressing with an assessment as the NICE recommendation will also apply to NHS Wales.